Acute Myeloid Leukemia Treatment Market Outlook 2025–2030: Innovations, Clinical Developments, and Future Pathways
Acute Myeloid Leukemia (AML) is a complex, aggressive hematological malignancy characterized by the uncontrolled proliferation of immature myeloid cells in the bone marrow and blood. Despite decades of research, AML remains a significant clinical challenge due to its heterogeneity, rapid progression, and high relapse rates. The period from 2025 to 2030 is expected to witness unprecedented...
0 Commentaires 0 Parts 207 Vue 0 Aperçu
Commandité